Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Erenumab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amgen's Biologic Aimovig (Erenumab) Receives Approval in the U.S.
    Amgen's Biologic Aimovig (Erenumab) Receives Approval in the U.S.

    03 Oct 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761077

    FDA
    03 Oct 2022
    Share Share
    Amgen's Biologic Aimovig (Erenumab-Aooe) Receives Approval in the U.S.
    Amgen's Biologic Aimovig (Erenumab-Aooe) Receives Approval in the U.S.

    15 Aug 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761077

    FDA
    15 Aug 2022
    Share Share
    Novartis, Amgen settle their yearslong Aimovig dispute
    Novartis, Amgen settle their yearslong Aimovig dispute

    02 Feb 2022

    // E. Sagonowsky FIERCEPHARMA

    https://www.fiercepharma.com/pharma/novartis-amgen-settle-their-dueling-lawsuits-over-migraine-drug-aimovig

    E. Sagonowsky FIERCEPHARMA
    02 Feb 2022
    Share Share
    Aimovig displays superiority over topiramate in migraine study
    Aimovig displays superiority over topiramate in migraine study

    09 Nov 2021

    // Anna Begley EUROPEANPHARMACEUTICALREVIEW

    https://www.europeanpharmaceuticalreview.com/news/165242/aimovigdisplays-superiority-over-topiramate-in-migraine-study/

    Anna Begley EUROPEANPHARMACEUTICALREVIEW
    09 Nov 2021
    Share Share
    AbbVie follows Biohaven into oral CGRP for migraine prevention
    AbbVie follows Biohaven into oral CGRP for migraine prevention

    29 Sep 2021

    // Angus Liu FIERCEPHARMA

    https://www.fiercepharma.com/pharma/abbvie-pressures-biohaven-migraine-prevention-fda-approval-for-cgrp-blockbuster-to-be

    Angus Liu FIERCEPHARMA
    29 Sep 2021
    Share Share
    AbbVie's oral migraine treatment atogepant nears FDA decision
    AbbVie's oral migraine treatment atogepant nears FDA decision

    20 Aug 2021

    // Annalee Armstrong FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/migraine-market-better-make-way-for-abbvie-as-oral-preventative-treatment-atogepant-poised

    Annalee Armstrong FIERCEBIOTECH
    20 Aug 2021
    Share Share